These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15467506)

  • 1. Cardiovascular disease in renal failure.
    Guerin AP; Adda H; London GM; Marchais SJ
    Minerva Urol Nefrol; 2004 Sep; 56(3):279-88. PubMed ID: 15467506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of left ventricular hypertrophy in dialysis patients.
    London GM; Guerin AP; Marchais SJ
    Blood Purif; 1994; 12(4-5):277-83. PubMed ID: 7865187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular alterations and end-stage renal disease.
    London GM
    Nephrol Dial Transplant; 2002; 17 Suppl 1():29-36. PubMed ID: 11812909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of cardiovascular disease in hemodialysis patients.
    Meeus F; Kourilsky O; Guerin AP; Gaudry C; Marchais SJ; London GM
    Kidney Int Suppl; 2000 Aug; 76():S140-7. PubMed ID: 10936811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diastolic dysfunction in chronic renal failure patients under hemodialysis].
    Douchet MP; Couppie P; Chantrel F; Kuntz C; Hannedouche T
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):589-92. PubMed ID: 9033698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of arteriovenous fistulae on the myocardium: the impact of creation and ligation in the transplant era.
    Duque JC; Gomez C; Tabbara M; Alfonso CE; Li X; Vazquez-Padron RI; Asif A; Lenz O; Briones PL; Salman LH
    Semin Dial; 2015; 28(3):305-10. PubMed ID: 25267110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Cardiovascular Reserve in Chronic Kidney Failure: A Matched Cohort Study.
    Ting SM; Hamborg T; McGregor G; Oxborough D; Lim K; Koganti S; Aldridge N; Imray C; Bland R; Fletcher S; Krishnan NS; Higgins RM; Townend J; Banerjee P; Zehnder D
    Am J Kidney Dis; 2015 Aug; 66(2):274-84. PubMed ID: 25900597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors.
    London GM; Marchais SJ; Guerin AP; Metivier F; Pannier B
    Kidney Int Suppl; 1993 Jun; 41():S42-9. PubMed ID: 8320946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.
    Schmid H; Schiffl H; Lederer SR
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):465-70. PubMed ID: 21738032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
    Radermacher J; Koch KM
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S56-60. PubMed ID: 8608665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
    Wang AY; Li PK; Lui SF; Sanderson JE
    Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
    London GM
    Semin Dial; 2003; 16(2):85-94. PubMed ID: 12641870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
    Covic A; Voroneanu L; Goldsmith D
    Nephron Clin Pract; 2010; 116(3):c187-95. PubMed ID: 20606478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac anomalies in chronic renal failure].
    Guérin A; Marchais S; Pannier B; London G
    Presse Med; 2000 Feb; 29(5):274-80. PubMed ID: 10701411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cardiovascular risk after renal transplantation (1): Hypertension and left ventricular hypertrophy].
    Covic A; Gusbeth-Tatomir P; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):651-6. PubMed ID: 12092214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease.
    Zoccali C; Benedetto F; Mallamaci F; Tripepi G; Cutrupi S; Pizzini P; Malatino LS; Bonanno G; Seminara G
    J Hypertens; 2006 Oct; 24(10):2039-46. PubMed ID: 16957565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.